Literature DB >> 28993461

Brucella abortus Promotes a Fibrotic Phenotype in Hepatic Stellate Cells, with Concomitant Activation of the Autophagy Pathway.

Paula Constanza Arriola Benitez1, Ayelén Ivana Pesce Viglietti1, Claudia Karina Herrmann2, Vida A Dennis3, Diego José Comerci2, Guillermo Hernán Giambartolomei1, María Victoria Delpino4.   

Abstract

The liver is frequently affected in patients with active brucellosis. The present study demonstrates that Brucella abortus infection induces the activation of the autophagic pathway in hepatic stellate cells to create a microenvironment that promotes a profibrogenic phenotype through the induction of transforming growth factor-β1 (TGF-β1), collagen deposition, and inhibition of matrix metalloproteinase-9 (MMP-9) secretion. Autophagy was revealed by upregulation of the LC3II/LC3I ratio and Beclin-1 expression as well as inhibition of p62 expression in infected cells. The above-described findings were dependent on the type IV secretion system (VirB) and the secreted BPE005 protein, which were partially corroborated using the pharmacological inhibitors wortmannin, a phosphatidyl inositol 3-kinase inhibitor, and leupeptin plus E64 (inhibitors of lysosomal proteases). Activation of the autophagic pathway in hepatic stellate cells during Brucella infection could have an important contribution to attenuating inflammatory hepatic injury by inducing fibrosis. However, with time, B. abortus infection induced Beclin-1 cleavage with concomitant cleavage of caspase-3, indicating the onset of apoptosis of LX-2 cells, as was confirmed by the terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay and Hoechst staining. These results demonstrate that the cross talk of LX-2 cells and B. abortus induces autophagy and fibrosis with concomitant apoptosis of LX-2 cells, which may explain some potential mechanisms of liver damage observed in human brucellosis.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Brucella; liver

Mesh:

Substances:

Year:  2017        PMID: 28993461      PMCID: PMC5736806          DOI: 10.1128/IAI.00522-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Brucellosis; epidemiology, clinical manifestations, diagnosis.

Authors:  W W SPINK
Journal:  Semin Int       Date:  1956

2.  Complications associated with Brucella melitensis infection: a study of 530 cases.

Authors:  J D Colmenero; J M Reguera; F Martos; D Sánchez-De-Mora; M Delgado; M Causse; A Martín-Farfán; C Juárez
Journal:  Medicine (Baltimore)       Date:  1996-07       Impact factor: 1.889

Review 3.  Brucellosis.

Authors:  Georgios Pappas; Nikolaos Akritidis; Mile Bosilkovski; Epameinondas Tsianos
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

4.  Brucella hepatitis leading to cirrhosis of the liver.

Authors:  N B McCULLOUGH; C W EISELE
Journal:  AMA Arch Intern Med       Date:  1951-12

5.  Identification of a Brucella spp. secreted effector specifically interacting with human small GTPase Rab2.

Authors:  Marie de Barsy; Alexandre Jamet; Didier Filopon; Cécile Nicolas; Géraldine Laloux; Jean-François Rual; Alexandre Muller; Jean-Claude Twizere; Bernard Nkengfac; Jean Vandenhaute; David E Hill; Suzana P Salcedo; Jean-Pierre Gorvel; Jean-Jacques Letesson; Xavier De Bolle
Journal:  Cell Microbiol       Date:  2011-05-30       Impact factor: 3.715

6.  Granulocyte-macrophage colony-stimulating factor- and tumor necrosis factor alpha-mediated matrix metalloproteinase production by human osteoblasts and monocytes after infection with Brucella abortus.

Authors:  Romina Scian; Paula Barrionuevo; Guillermo H Giambartolomei; Carlos A Fossati; Pablo C Baldi; M Victoria Delpino
Journal:  Infect Immun       Date:  2010-10-18       Impact factor: 3.441

7.  Inactivation of the type IV secretion system reduces the Th1 polarization of the immune response to Brucella abortus infection.

Authors:  Hortensia García Rolán; Renée M Tsolis
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

8.  The Beclin 1 interactome.

Authors:  Congcong He; Beth Levine
Journal:  Curr Opin Cell Biol       Date:  2010-01-22       Impact factor: 8.382

9.  Brucella modulates secretory trafficking via multiple type IV secretion effector proteins.

Authors:  Sebenzile Myeni; Robert Child; Tony W Ng; John J Kupko; Tara D Wehrly; Stephen F Porcella; Leigh A Knodler; Jean Celli
Journal:  PLoS Pathog       Date:  2013-08-08       Impact factor: 6.823

Review 10.  The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy.

Authors:  Mónika Lippai; Péter Lőw
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

View more
  5 in total

Review 1.  Self-eating: friend or foe? The emerging role of autophagy in fibrotic diseases.

Authors:  Yajing Li; Runping Liu; Jianzhi Wu; Xiaojiaoyang Li
Journal:  Theranostics       Date:  2020-06-29       Impact factor: 11.556

Review 2.  Bacteria Exploit Autophagy For Their Own Benefit.

Authors:  Qiuhong Xiong; Min Yang; Ping Li; Changxin Wu
Journal:  Infect Drug Resist       Date:  2019-10-11       Impact factor: 4.003

3.  miR-146b-5p Plays a Critical Role in the Regulation of Autophagy in ∆per Brucella melitensis-Infected RAW264.7 Cells.

Authors:  Jiao Hanwei; Xin Nie; Huapei Zhu; Baobao Li; Feng Pang; Xiaohong Yang; Ruiyong Cao; Xiaojian Yang; Shu Zhu; Dongmei Peng; Yaying Li; Guohua Li; Zhenxing Zhang; Haifeng Huang; Kailian Xu; Tianjing Zhao; Ying Cheng; Chuangfu Chen; Li Du; Fengyang Wang
Journal:  Biomed Res Int       Date:  2020-01-19       Impact factor: 3.411

Review 4.  Uncovering the Hidden Credentials of Brucella Virulence.

Authors:  R Martin Roop; Ian S Barton; Dariel Hopersberger; Daniel W Martin
Journal:  Microbiol Mol Biol Rev       Date:  2021-02-10       Impact factor: 11.056

Review 5.  Immunopathogenesis of Hepatic Brucellosis.

Authors:  Guillermo Hernán Giambartolomei; María Victoria Delpino
Journal:  Front Cell Infect Microbiol       Date:  2019-12-20       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.